TARDBP and amyotrophic lateral sclerosis: Similar pathophysiological mechanisms are described for both genetic and sporadic ALS patients, and as 97% of ALS patients present TDP-43 aggregation, it is plausible to suggest a link between TDP-43 and some of the pathogenic mechanisms [4,5].